Home Business Major drugmaker loses $27 billion in market value after failed trial
Business

Major drugmaker loses $27 billion in market value after failed trial

Share
Major drugmaker loses  billion in market value after failed trial
Share


Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial.

Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep in touch

Subscribe to our newsletter to get our newest articles instantly!

    Copyright 2025. All rights reserved